Latest news News from the International Liver Congress 2022Read our summary bulletin of news from the conference in English, Spanish, Russian, French and Portuguese. Dr Kosh Agarwal discusses results of the REEF-2 study at the International LIver Congress. Photo © Steve Forrest & Andrew McConnell / EASL.New & experimental hepatitis B treatmentsExperimental hepatitis B combination suppresses key marker but fails to achieve functional cure. Liver transplantsShort-course treatment prevents hepatitis C after organ transplant. infohep news Widespread PrEP use is not leading to more hepatitis C transmission among gay and bisexual men Keith Alcorn / 03 August 2022 The incidence of hepatitis C infection is now four times lower in gay and bisexual PrEP users than it was before direct-acting antivirals for the treatment of hepatitis C became ... Biktarvy combination pill may be most effective option for people with HIV and hepatitis B Liz Highleyman / 03 August 2022 Although two antiretroviral drug regimens proved about equally effective at suppressing HIV, the Biktarvy combination pill (bictegravir, emtricitabine and tenofovir alafenamide) did a better job suppressing hepatitis B virus (HBV) ... View all infohep news Editors' picks from other sources New NHS programme to find and cure hidden Hepatitis C NHS England / 03 August 2022 Likely cause of mystery child hepatitis outbreak found BBC / 25 July 2022 WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics World Health Organization / 24 June 2022 View all news from other sources Noticeboard ILC 2016 webinar: watch again More noticeboard posts Email updates Sign up for our monthly bulletins Sign up today Other pages in this section Latest news All the news Conference news Noticeboard Email bulletins News feeds